[PHARMACOLOGICAL POSSIBILITIES FOR PROLONGING THE RECOVERY TIME OF THE HEART AFTER CIRCULATORY ARREST IN NORMOTHERMIA].
D000227:Adenine Nucleotides; D000818:Animals; D001831:Body Temperature; D004176:Dipyridamole; D004285:Dogs; D004583:Electrons; D006003:Glycogen; D006321:Heart; D006323:Heart Arrest; D006324:Heart Arrest, Induced; D007455:Iodine; D008660:Metabolism; D008853:Microscopy; D008854:Microscopy, Electron; D009206:Myocardium; D010743:Phospholipids; D011817:Rabbits; D012106:Research; D013963:Thyroid Hormones
D000227:Adenine Nucleotides; D010743:Phospholipids; D013963:Thyroid Hormones; D004176:Dipyridamole; D006003:Glycogen; D007455:Iodine
ADENINE NUCLEOTIDES; BODY TEMPERATURE; DIPYRIDAMOLE; DOGS; EXPERIMENTAL LAB STUDY; GLYCOGEN; HEART ARREST, INDUCED; IODINE; METABOLISM; MICROSCOPY, ELECTRON; MYOCARDIUM; PHOSPHOLIPIDS; RABBITS; THYROID HORMONES
PHARMAKOLOGISCHE MOEGLICHKEITEN ZUR VERLAENGERUNG DER WIEDERBELEBUNGSZEIT DES HERZENS NACH KREISLAUFUNTERBRECHUNG IN NORMOTHERMIE.